Skip to main content

Advertisement

SpringerLink
Log in

Pluripotent-derived Mesenchymal Stem/stromal Cells: an Overview of the Derivation Protocol Efficacies and the Differences Among the Derived Cells

  • Published:
Stem Cell Reviews and Reports Aims and scope Submit manuscript

Abstract

Mesenchymal stem/stromal cells (MSCs) are remarkable tools for regenerative medicine. Therapeutic approaches using these cells can promote increased activity and viability in several cell types through diverse mechanisms such as paracrine and immunomodulatory activities, contributing substantially to tissue regeneration and functional recovery. However, biological samples of human MSCs, usually obtained from adult tissues, often exhibit variable behavior during in vitro culture, especially with respect to cell population heterogeneity, replicative senescence, and consequent loss of functionality. Accordingly, it is necessary to establish standard protocols to generate high-quality, stable cell cultures, for example, by using pluripotent stem cells (PSCs) in derivation protocols of MSC-like cells since PSCs maintain their characteristics consistently during culture. However, the available protocols seem to generate distinct populations of PSC-derivedMSCs (PSC-MSCs) with peculiar attributes, which do not always resemble bona fide primary MSCs. The present review addresses the developmental basis behind some of these derivation protocols, exposing the differences among them and discussing the functional properties of PSC-MSCs, shedding light on elements that may help determine standard characterizations and criteria to evaluate and define these cells.

Graphic Abstract

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

Data Availability

Not applicable.

Code Availability

Not applicable.

References

  1. Viswanathan, S., Shi, Y., Galipeau, J., Krampera, M., Leblanc, K., Martin, I., & Sensebe, L. (2019). Mesenchymal stem versus stromal cells: International Society for Cell & Gene Therapy (ISCT®) Mesenchymal Stromal Cell committee position statement on nomenclature. Cytotherapy, 21(10), 1019–1024

    Article  CAS  PubMed  Google Scholar 

  2. Friedenstein, A. J., Piatetzky-Shapiro, I. I., & Petrakova, K. V. (1966). Osteogenesis in transplants of bone marrow cells. Journal of Embryology and Experimental Morphology, 16(3), 381–390

    CAS  PubMed  Google Scholar 

  3. Castro-Malaspina, H., Gay, R. E., Resnick, G., Kapoor, N., Meyers, P., Chiarieri, D., & Moore, M. A. S. (1980). Characterization of human bone marrow fibroblast colony-forming cells (CFU-F) and their progeny. Blood, 56(2), 289–301

    Article  CAS  PubMed  Google Scholar 

  4. da Silva Meirelles, L., Chagastelles, P. C., & Nardi, N. B. (2006). Mesenchymal stem cells reside in virtually all post-natal organs and tissues. Journal of Cell Science, 119(11), 2204–2213

    Article  PubMed  Google Scholar 

  5. Dominici, M., Le Blanc, K., Mueller, I., Slaper-Cortenbach, I., Marini, F. C., Krause, D. S., & Horwitz, E. M. (2006). Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy, 8(4), 315–317

    Article  CAS  PubMed  Google Scholar 

  6. Bourin, P., Bunnell, B. A., Casteilla, L., Dominici, M., Katz, A. J., March, K. L., & Gimble, J. M. (2013). Stromal cells from the adipose tissue-derived stromal vascular fraction and culture expanded adipose tissue-derived stromal/ stem cells: a joint statement of the International Federation for Adipose Therapeutics (IFATS) and Science and the International S. Cytotherapy, 15(6), 641–648

    Article  PubMed  PubMed Central  Google Scholar 

  7. Angulski, A. B. B., Capriglione, L. G., Batista, M., Marcon, B. H., Senegaglia, A. C., Stimamiglio, M. A., & Correa, A. (2017). The protein content of extracellular vesicles derived from expanded human umbilical cord blood-derived CD133 + and human bone marrow-derived mesenchymal stem cells partially explains why both sources are advantageous for regenerative medicine. Stem Cell Reviews and Reports, 13(2), 244–257

    Article  CAS  PubMed  Google Scholar 

  8. Uccelli, A., Mancardi, G., & Chiesa, S. (2008). Is there a role for mesenchymal stem cells in autoimmune diseases? Autoimmunity, 41(8), 592–595

    Article  CAS  PubMed  Google Scholar 

  9. Phinney, D. G. (2012). Functional heterogeneity of mesenchymal stem cells: implications for cell therapy. Journal of Cellular Biochemistry, 113(9), 2806–2812

    Article  CAS  PubMed  Google Scholar 

  10. Robert, A. W., Marcon, B. H., Dallagiovanna, B., & Shigunov, P. (2020). Adipogenesis, osteogenesis, and chondrogenesis of human mesenchymal stem/stromal cells: a comparative transcriptome approach. Frontiers in Cell and Developmental Biology, 8(561), 1–52

    Google Scholar 

  11. Horinouchi, C. D. S., Barisón, M. J., Robert, A. W., Kuligovski, C., Aguiar, A. M., & Dallagiovanna, B. (2020). Influence of donor age on the differentiation and division capacity of human adipose-derived stem cells. World Journal of Stem Cells, 12(12), 1640–1651

    Article  PubMed  PubMed Central  Google Scholar 

  12. Russell, K. C., Phinney, D. G., Lacey, M. R., Barrilleaux, B. L., Meyertholen, K. E., & O’Connor, K. C. (2010). In vitro high-capacity assay to quantify the clonal heterogeneity in trilineage potential of mesenchymal stem cells reveals a complex hierarchy of lineage commitment. Stem Cells, 28(4), 788–798

    Article  CAS  PubMed  Google Scholar 

  13. Russell, K. C., Lacey, M. R., Gilliam, J. K., Tucker, H. A., Phinney, D. G., & O’Connor, K. C. (2011). Clonal analysis of the proliferation potential of human bone marrow mesenchymal stem cells as a function of potency. Biotechnology and Bioengineering, 108(11), 2716–2726

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  14. Galipeau, J. (2013). The mesenchymal stromal cells dilemma-does a negative phase III trial of random donor mesenchymal stromal cells in steroid-resistant graft-versus-host disease represent a death knell or a bump in the road? Cytotherapy, 15(1), 2–8

    Article  PubMed  Google Scholar 

  15. Thomson, J. A., Itskovitz-Eldor, J., Shapiro, S. S., Waknitz, M. A., Swiergiel, Jennifer, J., Marshall, V. S., & Jones, J. M. (1998). Embryonic stem cell lines derived from human blastocysts. Science, 282(5391), 1145–1147

    Article  CAS  PubMed  Google Scholar 

  16. Xu, C., Jiang, J., Sottile, V., McWhir, J., Lebrowski, J., & Carpenter, M. K. (2004). Immortalized fibroblast-Like cells derived from human embryonic stem cells support undifferentiated cell growth. Stem Cells, 22(1), 972–980

    Article  CAS  PubMed  Google Scholar 

  17. Hwang, N. S., Varghese, S., Zhang, Z., & Elisseeff, J. (2006). Chondrogenic differentiation of human embryonic stem cell-derived cells in arginine-glycine-aspartate modified hydrogels. Tissue Engineering, 12(9), 2695–2706

    Article  CAS  PubMed  Google Scholar 

  18. Hwang, N. S., Varghese, S., Lee, H. J., Zhang, Z., Ye, Z., Bae, J., & Elisseeff, J. (2008). In vivo commitment and functional tissue regeneration using human embryonic stem cell-derived mesenchymal cells. Proceedings of the National Academy of Sciences of the United States of America, 105(52), 20641–20646

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  19. Olivier, E. N., Rybicki, A. C., & Bouhassira, E. E. (2006). Differentiation of human embryonic stem cells into bipotent mesenchymal stem cells. Stem Cells, 24(8), 1914–1922

    Article  CAS  PubMed  Google Scholar 

  20. Yen, B. L., Chang, C. J., Liu, K. J., Chen, Y. C., Hu, H. I., Bai, C. H., & Yen, M. L. (2009). Brief report-human embryonic stem cell-derived mesenchymal progenitors possess strong immunosuppressive effects toward natural killer cells as well as T lymphocytes. Stem Cells, 27(2), 451–456

    Article  PubMed  Google Scholar 

  21. Moslem, M., Valojerdi, M. R., Pournasr, B., Muhammadnejad, A., & Baharvand, H. (2013). Therapeutic potential of human induced pluripotent stem cell-derived mesenchymal stem cells in mice with lethal fulminant hepatic failure. Cell Transplantation, 22(10), 1785–1799

    Article  PubMed  Google Scholar 

  22. Trivedi, P., & Hematti, P. (2008). Derivation and immunological characterization of mesenchymal stromal cells from human embryonic stem cells. Experimental Hematology, 36(3), 350–359

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  23. Arpornmaeklong, P., Brown, S. E., Wang, Z., & Krebsbach, P. H. (2009). Phenotypic characterization, osteoblastic differentiation, and bone regeneration capacity of human embryonic stem cell-derived mesenchymal stem cells. Stem Cells and Development, 18(7), 955–968

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  24. Villa-Diaz, L. G., Brown, S. E., Liu, Y., Ross, A., Lahann, J., Parent, J. M., & Krebsbach, P. H. (2012). Derivation of functional mesenchymal stem cells from human induced pluripotent stem cells culture on synthetic polymer substrates. Stem Cells, 30(6), 1174–1181

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  25. Brown, S. E., Tong, W., & Krebsbach, P. H. (2009). The derivation of mesenchymal stem cells from human embryonic stem cells. Cells, Tissues, Organs, 189(1–4), 256–260

    Article  PubMed  Google Scholar 

  26. Karlsson, C., Emanuelsson, K., Wessberg, F., Kajic, K., Axell, M. Z., Eriksson, P. S., & Strehl, R. (2009). Human embryonic stem cell-derived mesenchymal progenitors-Potential in regenerative medicine. Stem Cell Research, 3(1), 39–50

    Article  PubMed  Google Scholar 

  27. De Peppo, G. M., Svensson, S., Lennerås, M., Synnergren, J., Stenberg, J., Strehl, R., & Karlsson, C. (2010). Human embryonic mesodermal progenitors highly resemble human mesenchymal stem cells and display high potential for tissue engineering applications. Tissue Engineering - Part A, 16(7), 2161–2182

    Article  PubMed  Google Scholar 

  28. De Peppo, G. M., Sjovall, P., Lennerås, M., Strehl, R., Hyllner, J., Thomsen, P., & Karlsson, C. (2010). Osteogenic potential of human mesenchymal stem cells and human embryonic stem cell-derived mesodermal progenitors: a tissue engineering perspective. Tissue Engineering - Part A, 16(11), 3413–3426

    Article  PubMed  Google Scholar 

  29. De Peppo, G. M., Sladkova, M., Sjövall, P., Palmquist, A., Oudina, K., Hyllner, J., & Karlsson, C. (2013). Human embryonic stem cell-derived mesodermal progenitors display substantially increased tissue formation compared to human mesenchymal stem cells under dynamic culture conditions in a packed Bed/Column bioreactor. Tissue Engineering - Part A, 19(1–2), 175–187

    Article  PubMed  Google Scholar 

  30. Li, O., Tormin, A., Sundberg, B., Hyllner, J., Le Blanc, K., & Scheding, S. (2013). Human embryonic stem cell-derived mesenchymal stroma cells (hES-MSCs) engraft in vivo and support hematopoiesis without suppressing immune function: implications for off-the shelf ES-MSC therapies. PLoS One1, 8(1), 1–9

    Google Scholar 

  31. Stavropoulos, M. E., Mengarelli, I., & Barberi, T. (2009). Differentiation of multipotent mesenchymal precursors and skeletal myoblasts from human embryonic stem cells. Current Protocols in Stem Cell Biology, Chap, 1(Supplement 9), 1–10

    Google Scholar 

  32. Hu, J., Smith, L. A., Feng, K., Liu, X., Sun, H., & Ma, P. X. (2010). Response of human embryonic stem cell-derived mesenchymal stem cells to osteogenic factors and architectures of materials during in vitro osteogenesis. Tissue Engineering - Part A, 16(11), 3507–3514

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  33. Fu, X., Chen, Y., Xie, F. N., Dong, P., Liu, W. B., Cao, Y., & Xiao, R. (2015). Comparison of immunological characteristics of mesenchymal stem cells derived from human embryonic stem cells and bone marrow. Tissue Engineering - Part A, 21(3–4), 616–626

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  34. Barbet, R., Peiffer, I., Hatzfeld, A., Charbord, P., & Hatzfeld, J. A. (2011). Comparison of gene expression in human embryonic stem cells, hESC-derived mesenchymal stem cells and human mesenchymal stem cells. Stem Cells International, 2011(1), 1–9

    Article  Google Scholar 

  35. Giuliani, M., Oudrhiri, N., Noman, Z. M., Vernochet, A., Chouaib, S., Azzarone, B., & Bennaceur-Griscelli, A. (2011). Human mesenchymal stem cells derived from induced pluripotent stem cells down-regulate NK-cell cytolytic machinery. Blood, 118(12), 3254–3262

    Article  CAS  PubMed  Google Scholar 

  36. Gruenloh, W., Kambal, A., Sondergaard, C., McGee, J., Nacey, C., Kalomoiris, S., & Nolta, J. A. (2011). Characterization and in vivo testing of mesenchymal stem cells derived from human embryonic stem cells. Tissue Engineering - Part A, 17(11–12), 1517–1525

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  37. Harkness, L., Mahmood, A., Ditzel, N., Abdallah, B. M., Nygaard, J. V., & Kassem, M. (2011). Selective isolation and differentiation of a stromal population of human embryonic stem cells with osteogenic potential. Bone, 48(2), 231–241

    Article  CAS  PubMed  Google Scholar 

  38. Ahfeldt, T., Schinzel, R. T., Lee, Y. K., Hendrickson, D., Kaplan, A., Lum, D. H., & Cowan, C. A. (2012). Programming human pluripotent stem cells into white and brown adipocytes. Nature Cell Biology, 14(2), 209–219

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  39. Liu, Y., Goldberg, A. J., Dennis, J. E., Gronowicz, G. A., & Kuhn, L. T. (2012). One-step derivation of mesenchymal stem cell (MSC)-like cells from human pluripotent stem cells on a fibrillar collagen coating. PLoS One1, 7(3), 1–9

    Google Scholar 

  40. Yen, M. L., Hou, C. H., Peng, K. Y., Tseng, P. C., Jiang, S. S., Shun, C. T., & Kuo, M. L. (2011). Efficient derivation and concise gene expression profiling of human embryonic stem cell-derived mesenchymal progenitors (EMPs). Cell Transplantation, 20(10), 1529–1545

    Article  PubMed  Google Scholar 

  41. Zou, L., Luo, Y., Chen, M., Wang, G., Ding, M., Petersen, C. C., & Bünger, C. (2013). A simple method for deriving functional MSCs and applied for osteogenesis in 3D scaffolds. Scientific Reports, 3(2243), 1–10

    Google Scholar 

  42. Xia, Y., Ling, X., Hu, G., Zhu, Q., Zhang, J., Li, Q., & Deng, Z. (2020). Small extracellular vesicles secreted by human iPSC-derived MSC enhance angiogenesis through inhibiting STAT3-dependent autophagy in ischemic stroke. Stem Cell Research and Therapy, 11(313), 1–17

    Google Scholar 

  43. Kang, R., Luo, Y., Zou, L., Xie, L., Lysdahl, H., Jiang, X., & Bünger, C. (2014). Osteogenesis of human induced pluripotent stem cells derived mesenchymal stem cells on hydroxyapatite contained nanofibers. RSC Advances, 4(11), 5734–5739

    Article  CAS  Google Scholar 

  44. Kang, R., Zhou, Y., Tan, S., Zhou, G., Aagaard, L., Xie, L., & Luo, Y. (2015). Mesenchymal stem cells derived from human induced pluripotent stem cells retain adequate osteogenicity and chondrogenicity but less adipogenicity. Stem Cell Research and Therapy, 6(144), 1–14

    Google Scholar 

  45. Peng, K. Y., Lee, Y. W., Hsu, P. J., Wang, H. H., Wang, Y., Liou, J. Y., & Yen, B. L. (2016). Human pluripotent stem cell (PSC)-derived mesenchymal stem cells (MSCs) show potent neurogenic capacity which is enhanced with cytoskeletal rearrangement. Oncotarget, 7(28), 43949–43959

    Article  PubMed  PubMed Central  Google Scholar 

  46. Wang, L. T., Jiang, S. S., Ting, C. H., Hsu, P. J., Chang, C. C., Sytwu, H. K., & Yen, B. L. (2018). Differentiation of mesenchymal stem cells from human induced pluripotent stem cells results in downregulation of c-Myc and DNA replication pathways with immunomodulation toward CD4 and CD8 cells. Stem Cells, 36(1), 903–914

    Article  CAS  PubMed  Google Scholar 

  47. Zhou, Y., Liao, J., Fang, C., Mo, C., Zhou, G., & Luo, Y. (2018). One-step derivation of functional mesenchymal stem cells from human pluripotent stem cells. Bio-Protocol, 8(22), 1–21

    Article  Google Scholar 

  48. Luo, L., Zhou, Y., Zhang, C., Huang, J., Du, J., Liao, J., & Luo, Y. (2020). Feeder-free generation and transcriptome characterization of functional mesenchymal stromal cells from human pluripotent stem cells. Stem Cell Research, 48(1), 1–13

    CAS  Google Scholar 

  49. Zhang, J., Guan, J., Niu, X., Hu, G., Guo, S., Li, Q., & Wang, Y. (2015). Exosomes released from human induced pluripotent stem cells-derived MSCs facilitate cutaneous wound healing by promoting collagen synthesis and angiogenesis. Journal of Translational Medicine, 13(49), 1–14

    Google Scholar 

  50. Hu, G. W., Li, Q., Niu, X., Hu, B., Liu, J., Zhou, S. M., & Deng, Z. F. (2015). Exosomes secreted by human-induced pluripotent stem cell-derived mesenchymal stem cells attenuate limb ischemia by promoting angiogenesis in mice. Stem Cell Research and Therapy, 6(10), 1–15

    Google Scholar 

  51. Mahmood, A., Harkness, L., Abdallah, B. M., Elsafadi, M., Al-Nbaheen, M. S., Aldahmash, A., & Kassem, M. (2012). Derivation of stromal (skeletal and mesenchymal) stem-like cells from human embryonic stem cells. Stem Cells and Development, 21(17), 3114–3124

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  52. Marolt, D., Campos, I. M., Bhumiratana, S., Koren, A., Petridis, P., Zhang, G., & Vunjak-Novakovic, G. (2012). Engineering bone tissue from human embryonic stem cells. Proceedings of the National Academy of Sciences of the United States of America, 109(22), 8705–8709

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  53. De Peppo, G. M., Marcos-Campos, I., Kahler, D. J., Alsalman, D., Shang, L., Vunjak-Novakovic, G., & Marolt, D. (2013). Engineering bone tissue substitutes from human induced pluripotent stem cells. Proceedings of the National Academy of Sciences of the United States of America, 110(21), 8680–8685

    Article  PubMed  PubMed Central  Google Scholar 

  54. McGrath, M., Tam, E., Sladkova, M., Almanaie, A., Zimmer, M., & De Peppo, G. M. (2019). GMP-compatible and xeno-free cultivation of mesenchymal progenitors derived from human-induced pluripotent stem cells. Stem Cell Research and Therapy, 10(11), 1–13

    Google Scholar 

  55. Chen, W., Zhou, H., Weir, M. D., Tang, M., Bao, C., & Xu, H. H. K. (2013). Human embryonic stem cell-derived mesenchymal stem cell seeding on calcium phosphate cement-chitosan-rgd scaffold for bone repair. Tissue Engineering - Part A, 19(7–8), 915–927

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  56. Liu, J., Chen, W., Zhao, Z., & Xu, H. H. K. (2013). Reprogramming of mesenchymal stem cells derived from iPSCs seeded in biofunctionalized calcium phosphate scaffold for bone engineering. Biomaterials, 34(32), 1–22

    Article  Google Scholar 

  57. Wang, P., Liu, X., Zhao, L., Weir, M. D., Sin, J., Chen, W., & Xu, H. H. K. (2015). Bone tissue engineering via human induced pluripotent, umbilical cord and bone marrow mesenchymal stem cells in rat cranium. Acta Biomaterialia, 18(1), 236–248

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  58. Hynes, K., Menicanin, D., Han, J., Marino, V., Mrozik, K., Gronthos, S., & Bartold, P. M. (2013). Mesenchymal stem cells from iPS cells facilitate periodontal regeneration. Journal of Dental Research, 92(9), 833–839

    Article  CAS  PubMed  Google Scholar 

  59. Hynes, K., Menicanin, D., Mrozik, K., Gronthos, S., & Bartold, P. M. (2014). Generation of functional mesenchymal stem cells from different induced pluripotent stem cell lines. Stem Cells and Development, 23(10), 1084–1096

    Article  CAS  PubMed  Google Scholar 

  60. Ng, J., Hynes, K., White, G., Sivanathan, K. N., Vandyke, K., Bartold, P. M., & Gronthos, S. (2016). Immunomodulatory properties of induced pluripotent stem cell-derived mesenchymal cells. Journal of Cellular Biochemistry, 117(1), 2844–2853

    Article  CAS  PubMed  Google Scholar 

  61. Billing, A. M., Hamidane, B., Dib, H., Cotton, S. S., Bhagwat, R. J., Kumar, A. M., & Graumann, P. (2016). Comprehensive transcriptomic and proteomic characterization of human mesenchymal stem cells reveals source specific cellular markers. Scientific Reports, 6(21507), 1–15

    Google Scholar 

  62. Raynaud, C. M., Halabi, N., Elliott, D. A., Pasquier, J., Elefanty, A. G., Stanley, E. G., & Rafii, A. (2013). Human embryonic stem cell derived mesenchymal progenitors express cardiac markers but do not form contractile cardiomyocytes. PLoS One1, 8(1), 1–13

    Google Scholar 

  63. Theinhan, W., Liu, J., Tang, M., Chen, W., Cheng, L., & Xu, H. H. K. (2013). Induced pluripotent stem cell-derived mesenchymal stem cell seeding on biofunctionalized calcium phosphate cements. Bone Research, 4(1), 371–384

    Article  PubMed  Google Scholar 

  64. Diederichs, S., & Tuan, R. S. (2014). Functional comparison of human-induced pluripotent stem cell-derived mesenchymal cells and bone marrow-derived mesenchymal stromal cells from the same donor. Stem Cells and Development, 23(14), 1594–1610

    Article  PubMed  PubMed Central  Google Scholar 

  65. Umezaki, Y., Hashimoto, Y., Nishishita, N., Kawamata, S., & Baba, S. (2015). Human gingival integration-free iPSCs; a source for MSC-like cells. International Journal of Molecular Sciences, 16(6), 13633–13648

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  66. Gao, W. X., Sun, Y. Q., Shi, J., Li, C. L., Fang, S., Bin, Wang, D., & Fu, Q. L. (2017). Effects of mesenchymal stem cells from human induced pluripotent stem cells on differentiation, maturation, and function of dendritic cells. Stem Cell Research and Therapy, 8(48), 1–16

    Google Scholar 

  67. Lin, Y. D., Fan, X. L., Zhang, H., Fang, S., Bin, Li, C. L., Deng, M. X., & Fu, Q. L. (2018). The genes involved in asthma with the treatment of human embryonic stem cell-derived mesenchymal stem cells. Molecular Immunology, 95(1), 47–55

    Article  CAS  PubMed  Google Scholar 

  68. Kim, S., Lee, S. K., Kim, H., & Kim, T. M. (2018). Exosomes secreted from induced pluripotent stem cell-derived mesenchymal stem cells accelerate skin cell proliferation. International Journal of Molecular Sciences, 19(3119), 1–16

    Google Scholar 

  69. Wang, D., Sun, Y. Q., Gao, W. X., Fan, X. L., Shi, J. B., & Fu, Q. L. (2018). An in vitro and in vivo study of the effect of dexamethasone on immunoinhibitory function of induced pluripotent stem cell-derived mesenchymal stem cells. Cell Transplantation, 27(9), 1340–1351

    Article  PubMed  PubMed Central  Google Scholar 

  70. Billing, A. M., Dib, S. S., Bhagwat, A. M., da Silva, I. T., Drummond, R. D., Hayat, S., & Graumann, J. (2019). A systems-level characterization of the differentiation of human embryonic stem cells into mesenchymal stem cells. Molecular and Cellular Proteomics, 18(10), 1950–1966

    Article  PubMed  PubMed Central  Google Scholar 

  71. Xu, M., Shaw, G., Murphy, M., & Barry, F. (2019). Induced pluripotent stem cell-derived mesenchymal stromal cells are functionally and genetically different from bone marrow-derived mesenchymal stromal cells. Stem Cells, 37(6), 754–765

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  72. Cha, B. H., Kim, J. S., Bello, A., Lee, G. H., Kim, D. H., Kim, B. J., & Lee, S. H. (2020). Efficient isolation and enrichment of mesenchymal stem cells from human embryonic stem cells by utilizing the interaction between integrin α5β1 and fibronectin. Advanced Science, 7(17), 1–15

    Article  Google Scholar 

  73. Kwon, D., Ahn, H. J., Han, M. J., Ji, M., Ahn, J., Seo, K. W., & Kang, K. S. (2020). Human leukocyte antigen class I pseudo-homozygous mesenchymal stem cells derived from human induced pluripotent stem cells. Stem Cell Reviews and Reports, 16(4), 792–808

    Article  CAS  PubMed  Google Scholar 

  74. Wu, J., Song, D., Li, Z., Guo, B., Xiao, Y., Liu, W., & Hao, J. (2020). Immunity-and-matrix-regulatory cells derived from human embryonic stem cells safely and effectively treat mouse lung injury and fibrosis. Cell Research, 0(1–16), 794–809

    Article  CAS  Google Scholar 

  75. Frobel, J., Hemeda, H., Lenz, M., Abagnale, G., Joussen, S., Denecke, B., & Wagner, W. (2014). Epigenetic rejuvenation of mesenchymal stromal cells derived from induced pluripotent stem cells. Stem Cell Reports, 3(1), 1–9

    Google Scholar 

  76. Hollmann, J., Brecht, J., Goetzke, R., Franzen, J., Selich, A., Schmidt, M., & Wagner, W. (2020). Genetic barcoding reveals clonal dominance in iPSC-derived mesenchymal stromal cells. Stem Cell Research and Therapy, 11(105), 1–13

    Google Scholar 

  77. Fernandez-Rebollo, E., Franzen, J., Goetzke, R., Hollmann, J., Ostrowska, A., Oliverio, M., & Wagner, W. (2020). Senescence-associated metabolomic phenotype in primary and iPSC-derived mesenchymal stromal cells. Stem Cell Reports, 14(2), 201–209

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  78. Luzzani, C., Neiman, G., Garate, X., Questa, M., Solari, C., Fernandez Espinosa, D., & Miriuka, S. G. (2015). A therapy-grade protocol for differentiation of pluripotent stem cells into mesenchymal stem cells using platelet lysate as supplement. Stem Cell Research and Therapy, 6(6), 1–13

    Google Scholar 

  79. La Greca, A., Solari, C., Furmento, V., Lombardi, A., Biani, M. C., Aban, C., & Luzzani, C. (2018). Extracellular vesicles from pluripotent stem cell-derived mesenchymal stem cells acquire a stromal modulatory proteomic pattern during differentiation. Experimental and Molecular Medicine, 50(119), 1–12

    Article  PubMed  Google Scholar 

  80. Goetzke, R., Franzen, J., Ostrowska, A., Vogt, M., Blaeser, A., Klein, G., & Wagner, W. (2018). Does soft really matter? Differentiation of induced pluripotent stem cells into mesenchymal stromal cells is not influenced by soft hydrogels. Biomaterials, 156(1), 147–158

    Article  CAS  PubMed  Google Scholar 

  81. Barberi, T., Willis, L. M., Socci, N. D., & Studer, L. (2005). Derivation of multipotent mesenchymal precursors from human embryonic stem cells. PLoS Medicine, 2(6), 0554–0560

    Article  CAS  Google Scholar 

  82. Trivedi, P., & Hematti, P. (2007). Simultaneous generation of CD34 + primitive hematopoietic cells and CD73 + mesenchymal stem cells from human embryonic stem cells cocultured with murine OP9 stromal cells. Experimental Hematology, 35(1), 146–154

    Article  CAS  PubMed  Google Scholar 

  83. Kopher, R. A., Penchev, V. R., Islam, M. S., Hill, K. L., Khosla, S., & Kaufman, D. S. (2010). Human embryonic stem cell-derived CD34 + cells function as MSC progenitor cells. Bone, 47(4), 718–728

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  84. Evseenko, D., Zhu, Y., Schenke-Layland, K., Kuo, J., Latour, B., Ge, S., & Crooks, G. M. (2010). Mapping the first stages of mesoderm commitment during differentiation of human embryonic stem cells. Proceedings of the National Academy of Sciences of the United States of America, 107(31), 13742–13747

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  85. Chin, C. J., Cooper, A. R., Lill, G. R., Evseenko, D., Zhu, Y., He, C., & Bin, … Crooks, G. M. (2016). Genetic tagging during human mesoderm differentiation reveals tripotent lateral plate mesodermal progenitors. Stem Cells, 34(5), 1239–1250

  86. Chin, C. J., Li, S., Corselli, M., Casero, D., Zhu, Y., He, C., & Bin, … Crooks, G. M. (2018). Transcriptionally and functionally distinct mesenchymal subpopulations are generated from human pluripotent stem cells. Stem Cell Reports, 10(2), 436–446

  87. Vodyanik, M. A., Yu, J., Zhang, X., Tian, S., Stewart, R., Thomson, J. A., & Slukvin, I. I. (2010). A mesoderm-derived precursor for mesenchymal stem and endothelial cells. Cell Stem Cell, 7(6), 718–729

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  88. Brown, P. T., Squire, M. W., & Li, W. J. (2014). Characterization and evaluation of mesenchymal stem cells derived from human embryonic stem cells and bone marrow. Cell and Tissue Research, 358(1), 149–164

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  89. Xie, W., Schultz, M. D., Lister, R., Hou, Z., Rajagopal, N., Ray, P., & Ren, B. (2013). Epigenomic analysis of multilineage differentiation of human embryonic stem cells. Cell, 153(5), 1134–1148

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  90. Bloor, A. J. C., Patel, A., Griffin, J. E., Gilleece, M. H., Radia, R., Yeung, D. T., & Rasko, J. E. J. (2020). Production, safety and efficacy of iPSC-derived mesenchymal stromal cells in acute steroid-resistant graft versus host disease: a phase I, multicenter, open-label, dose-escalation study. Nature Medicine, 26(11), 1–15

    Article  Google Scholar 

  91. Tran, N. T., Trinh, Q. M., Lee, G. M., & Han, Y. M. (2012). Efficient differentiation of human pluripotent stem cells into mesenchymal stem cells by modulating intracellular signaling pathways in a feeder/serum-free system. Stem Cells and Development, 21(7), 1165–1175

    Article  CAS  PubMed  Google Scholar 

  92. Nakayama, C., Fujita, Y., Matsumura, W., Ujiie, I., Takashima, S., Shinkuma, S., & Shimizu, H. (2018). The development of induced pluripotent stem cell-derived mesenchymal stem/stromal cells from normal human and RDEB epidermal keratinocytes. Journal of Dermatological Science, 91(3), 301–310

    Article  CAS  PubMed  Google Scholar 

  93. Wei, H., Tan, G., Manasi, Qiu, S., Kong, G., Yong, P., & Shim, W. (2012). One-step derivation of cardiomyocytes and mesenchymal stem cells from human pluripotent stem cells. Stem Cell Research, 9(2), 87–100

    Article  CAS  PubMed  Google Scholar 

  94. Miao, Q., Shim, W., Tee, N., Lim, S. Y., Chung, Y. Y., Mia Ja, M., & Wong, K. P. (2014). iPSC-derived human mesenchymal stem cells improve myocardial strain of infarcted myocardium. Journal of Cellular and Molecular Medicine, 18(8), 1644–1654

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  95. Kimbrel, E. A., Kouris, N. A., Yavanian, G. J., Chu, J., Qin, Y., Chan, A., & Lanza, R. (2014). Mesenchymal stem cell population derived from human pluripotent stem cells displays potent immunomodulatory and therapeutic properties. Stem Cells and Development, 23(14), 1611–1624

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  96. Wang, X., Kimbrel, E. A., Ijichi, K., Paul, D., Lazorchak, A. S., Chu, J., & Xu, R. H. (2014). Human ESC-derived MSCs outperform bone marrow MSCs in the treatment of an EAE model of multiple sclerosis. Stem Cell Reports, 3(1), 115–130

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  97. Deng, P., Zhou, C., Alvarez, R., Hong, C., & Wang, C. Y. (2016). Inhibition of IKK/NF-κB signaling enhances differentiation of mesenchymal stromal cells from human embryonic stem cells. Stem Cell Reports, 6(4), 456–465

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  98. Yu, Y., Deng, P., Yu, B., Szymanski, J. M., Aghaloo, T., Hong, C., & Wang, C. Y. (2017). Inhibition of EZH2 promotes human embryonic stem cell differentiation into mesoderm by reducing H3K27me3. Stem Cell Reports, 9(3), 752–761

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  99. Lee, G., Kim, H., Elkabetz, Y., Shamy, A., Panagiotakos, G., Barberi, G., & Studer, T. (2007). Isolation and directed differentiation of neural crest stem cells derived from human embryonic stem cells. Nature Biotechnology, 25(12), 1468–1475

    Article  CAS  PubMed  Google Scholar 

  100. Menendez, L., Yatskievych, T. A., Antin, P. B., & Dalton, S. (2011). Wnt signaling and a smad pathway blockade direct the differentiation of human pluripotent stem cells to multipotent neural crest cells. Proceedings of the National Academy of Sciences of the United States of America, 108(48), 19240–19245

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  101. Fukuta, M., Nakai, Y., Kirino, K., Nakagawa, M., Sekiguchi, K., Nagata, S., & Toguchida, J. (2014). Derivation of mesenchymal stromal cells from pluripotent stem cells through a neural crest lineage using small molecule compounds with defined media. PLoS One1, 9(12), 1–25

    Google Scholar 

  102. Eto, S., Goto, M., Soga, M., Kaneko, Y., Uehara, Y., Mizuta, H., & Era, T. (2018). Mesenchymal stem cells derived from human iPS cells via mesoderm and neuroepithelium have different features and therapeutic potentials. PLoS One1, 13(7), 1–22

    Google Scholar 

  103. Zhang, L., Wang, H., Liu, C., Wu, Q., Su, P., Wu, D., & Zhou, J. (2018). MSX2 initiates and accelerates mesenchymal stem/stromal cell specification of hPSCs by regulating TWIST1 and PRAME. Stem Cell Reports, 11(2), 497–513

    Article  PubMed  PubMed Central  Google Scholar 

  104. Kamiya, D., Takenaka-Ninagawa, N., Motoike, S., Kajiya, M., Akaboshi, T., Zhao, C., & Ikeya, M. … (2020). Induction of functional mesenchymal stem/stromal cells from human iPSCs via a neural crest cell lineage under xeno-free conditions. Cell Reports Medicine, 1–69. Available at SSRN: https://ssrn.com/abstract=3741231 or https://doi.org/10.2139/ssrn.3741231

  105. Mitsuzawa, S., Zhao, C., Ikeguchi, R., Aoyama, T., Kamiya, D., Ando, M., & Ikeya, M. (2020). Pro-angiogenic scaffold-free bio three-dimensional conduit developed from human induced pluripotent stem cell-derived mesenchymal stem cells promotes peripheral nerve regeneration. Scientific Reports, 10(12034), 1–15

    Google Scholar 

  106. Yoshimatsu, M., Ohnishi, H., Zhao, C., Hayashi, Y., Kuwata, F., Kaba, S., & Omori, K. (2021). In vivo regeneration of rat laryngeal cartilage with mesenchymal stem cells derived from human induced pluripotent stem cells via neural crest cells. Stem Cell Research, 52, 1–12

    Article  Google Scholar 

  107. Wang, X., Lazorchak, A. S., Song, L., Li, E., Zhang, Z., Jiang, B., & Xu, R. H. (2016). Immune modulatory mesenchymal stem cells derived from human embryonic stem cells through a trophoblast-like stage. Stem Cells, 34(2), 380–391

    Article  CAS  PubMed  Google Scholar 

  108. Li, E., Zhang, Z., Jiang, B., Yan, L., Park, J. W., & Xu, R. H. (2018). Generation of mesenchymal stem cells from human embryonic stem cells in a complete serum-free condition. International Journal of Biological Sciences, 14(13), 1901–1909

    Article  PubMed  PubMed Central  Google Scholar 

  109. Yan, L., Jiang, B., Li, E., Wang, X., Ling, Q., Zheng, D., & Xu, R. H. (2018). Scalable generation of mesenchymal stem cells from human embryonic stem cells in 3D. International Journal of Biological Sciences, 14(10), 1196–1210

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  110. Lian, Q., Lye, E., Suan Yeo, K., Khia Way Tan, E., Salto-Tellez, M., Liu, T. M., & Lim, S. K. (2007). Derivation of clinically compliant MSCs from CD105+, CD24 – differentiated human ESCs. Stem Cells, 25(2), 425–436

    Article  CAS  PubMed  Google Scholar 

  111. Lian, Q., Zhang, Y., Zhang, J., Zhang, H. K., Wu, X., Zhang, Y., & Tse, H. F. (2010). Functional mesenchymal stem cells derived from human induced pluripotent stem cells attenuate limb ischemia in mice. Circulation, 121(9), 1113–1123

    Article  PubMed  Google Scholar 

  112. Zhang, Y., Liang, X., Liao, S., Wang, W., Wang, J., Li, X., & Lian, Q. (2015). Potent paracrine effects of human induced pluripotent stem cell-derived mesenchymal stem cells attenuate doxorubicin-induced cardiomyopathy. Scientific Reports, 5(11235), 1–17

    Google Scholar 

  113. Chen, T. S., Arslan, F., Yin, Y., Tan, S. S., Lai, R. C., Choo, A. B. H., & Lim, S. K. (2011). Enabling a robust scalable manufacturing process for therapeutic exosomes through oncogenic immortalization of human ESC-derived MSCs. Journal of Translational Medicine, 9(47), 1–10

    Google Scholar 

  114. Lai, R. C., Wee, R., Yeo, Y., Padmanabhan, J., Choo, A., Kleijn, D. P. V., & Lim, S. K. (2016). Isolation and characterization of exosome from human embryonic stem cell-derived C-Myc-immortalized mesenchymal stem cells. Methods in Molecular Biology, 1416(1), 477–494

    Article  CAS  PubMed  Google Scholar 

  115. Sze, S. K., de Kleijn, D. P. V., Lai, R. C., Tan, E. K. W., Zhao, H., Yeo, K. S., & Lim, S. K. (2007). Elucidating the secretion proteome of human embryonic stem cell-derived mesenchymal stem cells. Molecular and Cellular Proteomics, 6(10), 1680–1689

    Article  CAS  PubMed  Google Scholar 

  116. Zhang, J., Lian, Q., Zhu, G., Zhou, F., Sui, L., Tan, C., & Colman, A. (2011). A human iPSC model of Hutchinson Gilford Progeria reveals vascular smooth muscle and mesenchymal stem cell defects. Cell Stem Cell, 8(1), 31–45

    Article  CAS  PubMed  Google Scholar 

  117. Zhang, Y., Liao, S., Yang, M., Liang, X., Poon, M. W., Wong, C. Y., & Lian, Q. (2012). Improved cell survival and paracrine capacity of human embryonic stem cell-derived mesenchymal stem cells promote therapeutic potential for pulmonary arterial hypertension. Cell Transplantation, 21(10), 2225–2239

    Article  PubMed  Google Scholar 

  118. Fu, Q. L., Chow, Y. Y., Sun, S. J., Zeng, Q. X., Li, H. B., Shi, J. B., & Xu, G. (2012). Mesenchymal stem cells derived from human induced pluripotent stem cells modulate T-cell phenotypes in allergic rhinitis. Allergy: European Journal of Allergy and Clinical Immunology, 67(10), 1215–1222

    Article  CAS  PubMed  Google Scholar 

  119. Sun, Y. Q., Deng, M. X., He, J., Zeng, Q. X., Wen, W., Wong, D. S. H., & Fu, Q. L. (2012). Human pluripotent stem cell-derived mesenchymal stem cells prevent allergic airway inflammation in mice. Stem Cells, 30(12), 2692–2699

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  120. Cheng, P. P., Liu, X. C., Ma, P. F., Gao, C., Li, J. L., Lin, Y. Y., & Qi, Z. Q. (2015). IPSC-MSCs combined with low-dose rapamycin induced islet allograft tolerance through suppressing Th1 and enhancing regulatory T-Cell differentiation. Stem Cells and Development, 24(15), 1793–1804

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  121. Shi, H., Liang, M., Chen, W., Sun, X., Wang, X., Li, C., & Zeng, W. (2018). Human induced pluripotent stem cell-derived mesenchymal stem cells alleviate atherosclerosis by modulating inflammatory responses. Molecular Medicine Reports, 17(1), 1461–1468

    CAS  PubMed  Google Scholar 

  122. Jiang, D., Xiong, G., Feng, H., Zhang, Z., Chen, P., Yan, B., & Lian, Q. (2019). Donation of mitochondria by iPSC-derived mesenchymal stem cells protects retinal ganglion cells against mitochondrial complex I defect-induced degeneration. Theranostics, 9(8), 2395–2410

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  123. Boyd, N. L., Robbins, K. R., Dhara, S. K., West, F. D., & Stice, S. L. (2009). Human embryonic stem cell-derived mesoderm-like epithelium transitions to mesenchymal progenitor cells. Tissue Engineering - Part A, 15(8), 1897–1907

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  124. Mahmood, A., Harkness, L., Schrøder, H. D., Abdallah, B. M., & Kassem, M. (2010). Enhanced differentiation of human embryonic stem cells to mesenchymal progenitors by inhibition of TGF-β/activin/nodal signaling using SB-431542. Journal of Bone and Mineral Research, 25(6), 1216–1233

    Article  CAS  PubMed  Google Scholar 

  125. Sánchez, L., Gutierrez-Aranda, I., Ligero, G., Rubio, R., Muñoz-López, M., García-Pérez, J. L., & Menendez, P. (2011). Enrichment of human ESC-derived multipotent mesenchymal stem cells with immunosuppressive and anti-inflammatory properties capable to protect against experimental inflammatory Bowel disease. Stem Cells, 29(2), 251–262

    Article  PubMed  Google Scholar 

  126. Gonzalo-Gil, E., Pérez-Lorenzo, M. J., Galindo, M., de la Díaz, R., López-Millán, B., Bueno, C., & Criado, G. (2016). Human embryonic stem cell-derived mesenchymal stromal cells ameliorate collagen-induced arthritis by inducing host-derived indoleamine 2,3 dioxygenase. Arthritis Research and Therapy, 18(77), 1–9

    Google Scholar 

  127. Spitzhorn, L. S., Megges, M., Wruck, W., Rahman, M. S., Otte, J., Degistirici, Ã, & Adjaye, J. (2019). Human iPSC-derived MSCs (iMSCs) from aged individuals acquire a rejuvenation signature. Stem Cell Research and Therapy, 10(100), 1–18

    Google Scholar 

  128. Chen, Y. S., Pelekanos, R. A., Ellis, R. L., Horne, R., Wolvetang, E. J., & Fisk, N. M. (2012). Small molecule mesengenic induction of human induced pluripotent stem cells to generate mesenchymal stem/stromal cells. Stem Cells Translational Medicine, 1(1), 83–95

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  129. Leyendecker Junior, A. (2018). TGF-β Inhibitor SB431542 promotes the differentiation of induced pluripotent stem cells and embryonic stem cells into mesenchymal-like cells. Stem Cells International, 2018(1), 1–13

    Article  Google Scholar 

  130. Hawkins, K. E., Corcelli, M., Dowding, K., Ranzoni, A. M., Vlahova, F., Hau, K. L., & Guillot, P. V. (2018). Embryonic stem cell-derived mesenchymal stem cells (MSCs) have a superior neuroprotective capacity over fetal MSCs in the hypoxic-ischemic mouse brain. Stem Cells Translational Medicine, 7(5), 439–449

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  131. Spitzhorn, L. S., Kordes, C., Megges, M., Sawitza, I., Götze, S., Reichert, D., & Adjaye, J. (2018). Transplanted human pluripotent stem cell-derived mesenchymal stem cells support liver regeneration in Gunn rats. Stem Cells and Development, 27(24), 1702–1714

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  132. Jungbluth, P., Spitzhorn, L. S., Grassmann, J., Tanner, S., Latz, D., Rahman, M. S., & Adjaye, J. (2019). Human iPSC-derived iMSCs improve bone regeneration in mini-pigs. Bone Research, 7(32), 1–11

    CAS  Google Scholar 

  133. Zhao, Q., Gregory, C. A., Lee, R. H., Reger, R. L., Qin, L., Hai, B., & Liu, F. (2015). MSCs derived from iPSCs with a modified protocol are tumor-tropic but have much less potential to promote tumors than bone marrow MSCs. Proceedings of the National Academy of Sciences of the United States of America, 112(2), 530–535

    Article  CAS  PubMed  Google Scholar 

  134. Ullah, M., Kuroda, Y., Bartosh, T. J., Liu, F., Zhao, Q., Gregory, C., & Prockop, D. J. (2017). IPS-derived MSCS from an expandable bank to deliver a prodrug-converting enzyme that limits growth and metastases of human breast cancers. Cell Death Discovery, 3(1), 1–10

    Google Scholar 

  135. McNeill, E. P., Zeitouni, S., Pan, S., Haskell, A., Cesarek, M., Tahan, D., & Gregory, C. A. (2020). Characterization of a pluripotent stem cell-derived matrix with powerful osteoregenerative capabilities. Nature Communications, 11(3025), 1–15

    Google Scholar 

  136. Zhao, Q., Hai, B., Zhang, X., Xu, J., Koehler, B., & Liu, F. (2020). Biomimetic nanovesicles made from iPS cell-derived mesenchymal stem cells for targeted therapy of triple-negative breast cancer. Nanomedicine: Nanotechnology, Biology, and Medicine, 24, 1–11

    Google Scholar 

  137. Zhao, Q., Hai, B., Kelly, J., Wu, S., & Liu, F. (2021). Extracellular vesicle mimics made from iPS cell-derived mesenchymal stem cells improve the treatment of metastatic prostate cancer. Stem Cell Research and Therapy, 12(29), 1–13

    CAS  Google Scholar 

  138. Sheyn, D., Ben-David, S., Shapiro, G., De Mel, S., Bez, M., Ornelas, L., & Gazit, Z. (2016). Human induced pluripotent stem cells differentiate into functional mesenchymal stem cells and repair bone defects. Stem Cells Translational Medicine, 5, 1447–1460

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  139. Karam, M., Younis, I., Elareer, N. R., Nasser, S., & Abdelalim, E. M. (2020). Scalable generation of mesenchymal stem cells and adipocytes from human pluripotent stem cells. Cells, 9(710), 1–23

    Google Scholar 

  140. Zhang, L., Wei, Y., Chi, Y., Liu, D., Yang, S., Han, Z., & Li, Z. (2021). Two-step generation of mesenchymal stem/stromal cells from human pluripotent stem cells with reinforced efficacy upon osteoarthritis rabbits by HA hydrogel. Cell and Bioscience, 11(6), 1–17

    Google Scholar 

  141. Guiotto, M., Raffoul, W., Hart, A. M., Riehle, M. O., & Di Summa, P. G. (2020). Human platelet lysate to substitute fetal bovine serum in hMSC expansion for translational applications: a systematic review. Journal of Translational Medicine, 18(351), 1–14

    Google Scholar 

  142. Andrzejewska, A., Lukomska, B., & Janowski, M. (2019). Concise review: mesenchymal stem cells: from roots to boost. Stem Cells, 37(7), 855–864

    Article  PubMed  PubMed Central  Google Scholar 

  143. Sheng, G. (2015). The developmental basis of mesenchymal stem/stromal cells (MSCs). BMC Developmental Biology, 15(44), 1–8

    Google Scholar 

  144. Slukvin, I. I., & Kumar, A. (2018). The mesenchymoangioblast, mesodermal precursor for mesenchymal and endothelial cells. Cellular and Molecular Life Sciences, 75(19), 3507–3520

    Article  CAS  PubMed  Google Scholar 

  145. Lamouille, S., Xu, J., & Derynck, R. (2014). Molecular mechanisms of epithelial-mesenchymal transition. Nature Reviews Molecular Cell Biology, 15(3), 178–196

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  146. Chen, T., You, Y., Jiang, H., & Wang, Z. Z. (2017). Epithelial–mesenchymal transition (EMT): A biological process in the development, stem cell differentiation, and tumorigenesis. Journal of Cellular Physiology, 232(12), 3261–3272

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  147. Lu, S. J., Feng, Q., Caballero, S., Chen, Y., Moore, M. A. S., Grant, M. B., & Lanza, R. (2007). Generation of functional hemangioblasts from human embryonic stem cells. Nature Methods, 4(6), 1–18

    Article  Google Scholar 

  148. Lu, S. J., Luo, C., Holton, K., Feng, Q., Ivanova, Y., & Lanza, R. (2008). Robust generation of hemangioblastic progenitors from human embryonic stem cells. Regenerative Medicine, 3(5), 693–704

    Article  CAS  PubMed  Google Scholar 

  149. Wu, Q., Zhang, L., Su, P., Lei, X., Liu, X., Wang, H., & Zhou, J. (2015). MSX2 mediates entry of human pluripotent stem cells into mesendoderm by simultaneously suppressing SOX2 and activating NODAL signaling. Cell Research, 25(12), 1314–1332

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  150. Feng, X. H., & Derynck, R. (2005). Specificity and versatility in TGF-β signaling through smads. Annual Review of Cell and Developmental Biology, 21, 659–693

    Article  CAS  PubMed  Google Scholar 

  151. Mullen, A. C., & Wrana, J. L. (2017). TGF-β family signaling in embryonic and somatic stem-cell renewal and differentiation. Cold Spring Harbor Perspectives in Biology, 9(7), 1–33

    Article  Google Scholar 

Download references

Acknowledgements

MATOS, B.M. received a fellowship from Carlos Chagas Institute (ICC/FIOCRUZ-PR). We thank Wagner Nagib from the Communication Advisory (ASCOM/ICC) for helping to refine the illustrations of this review.

Author information

Author notes

  1. Bruno Moisés de Matos and Anny Waloski Robert contributed equally to this work.

Authors and Affiliations

  1. Carlos Chagas Institute (ICC/FIOCRUZ-PR), Curitiba, Brazil

    Bruno Moisés de Matos, Anny Waloski Robert, Marco Augusto Stimamiglio & Alejandro Correa

  2. Federal University of Paraná, Curitiba, Brazil

    Alejandro Correa

Authors
  1. Bruno Moisés de Matos
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Anny Waloski Robert
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Marco Augusto Stimamiglio
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Alejandro Correa
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

The idea of the article was conceived due to difficulties to reproduce published MSC derivation protocols. Bruno Moisés de Matos and Anny Waloski Robert performed literature research and data analysis. Marco Augusto Stimamiglio wrote the MSC state of the art introduction. Alejandro Correa, Bruno Moisés de Matos and Anny Waloski Robert contributed to writing the topics about derivation protocols. Graphical abstract, Figs. 2 and 3 were idealized by Bruno Moisés de Matos. Figures 1 and 4, as well as Tables 1 and 2 were idealized and formatted by Anny Waloski Robert. The work was critically revised by all authors, especially Marco Augusto Stimamiglio and Alejandro Correa. All authors approved the present manuscript.

Corresponding author

Correspondence to Alejandro Correa.

Ethics declarations

Conflict of Interest

The authors have no conflicts of interest to declare that are relevant to the content of this article.

Ethical Approval

Not applicable.

Consent to Participate

Not applicable. 

Consent to Publish

Not applicable.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

de Matos, B.M., Robert, A.W., Stimamiglio, M.A. et al. Pluripotent-derived Mesenchymal Stem/stromal Cells: an Overview of the Derivation Protocol Efficacies and the Differences Among the Derived Cells. Stem Cell Rev and Rep 18, 94–125 (2022). https://doi.org/10.1007/s12015-021-10258-z

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12015-021-10258-z

Keywords

Search

Navigation